EAM Investors, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 199 filers reported holding CLOVIS ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 0.94 and the average weighting 1.0%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2017$2,478,000
-37.4%
30,073
-28.9%
0.33%
-49.8%
Q2 2017$3,960,000
+7.5%
42,294
-26.9%
0.66%
+12.7%
Q1 2017$3,685,000
+26.5%
57,882
+82.7%
0.58%
+26.0%
Q3 2015$2,913,000
-31.1%
31,678
-34.1%
0.46%
-6.9%
Q2 2015$4,227,000
+332.7%
48,096
+229.8%
0.50%
+133.5%
Q2 2013$977,00014,5840.21%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2015
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 150,000$1,564,0004.60%
Healthcare Value Capital, LLC 100,000$1,043,0003.07%
Palo Alto Investors LP 5,056,286$52,712,0002.90%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,328,200$13,848,0001.53%
Ikarian Capital, LLC 513,700$5,355,0000.87%
Pinz Capital Management, LP 207,800$2,166,0000.79%
Leap Investments LP 146,300$1,525,0000.72%
Elk Creek Partners, LLC 574,616$5,990,0000.69%
SECTOR GAMMA AS 408,625$4,260,0000.68%
Artal Group S.A. 1,000,000$10,425,0000.40%
View complete list of CLOVIS ONCOLOGY INC shareholders